News Headlines, English News, Today Headlines, Top Stories | Arth Parkash

NEW DELHI — In a thorough regulatory move aimed at reducing self-medication and ensuring drug safety, the Government of India has banned the over-the-counter (OTC) sale of all medicinal syrups, including popular cough and cold medicines. Consumers across the country will now strictly require a valid doctor’s prescription to purchase any oral liquid medication.

The mandate came into immediate effect following a final gazette notification issued by the Ministry of Health and Family Welfare under the Drugs (Fifth Amendment) Rules, 2026.

The Legal Shift

To enforce this nationwide restriction, the Central Government amended the historic Drugs Rules, 1945. Specifically, regulators removed the word "syrups" from Schedule K of the Act.

Previously, Schedule K granted a wide range of exemptions to liquid oral mechanisms. It allowed shops to sell common cough and digestive syrups without requiring a formal prescription. Furthermore, it even permitted the sale of these liquids in remote villages by individuals who did not hold a formal retail drug license. By stripping syrups of this exempted status, the government has brought them under the same strict supervision governing standard prescription-only medications.

While the ban applies universally to all oral liquid syrups, the notification clarifies that solid alternatives—such as cough lozenges, throat pastilles, and tablets—remain exempted under Schedule K and can still be purchased OTC.

Why Now? Contamination and Abuse

The policy shift follows growing global and domestic oversight over India's pharmaceutical supply chain. According to health ministry officials, the restriction addresses two deeply rooted public health crises:

1. Substandard Drugs and Fatalities: Over the last few years, Indian-manufactured cough syrups faced international backlash after being linked to acute kidney injuries and dozens of child fatalities in nations like Gambia and Uzbekistan. Domestically, recent clusters of child deaths linked to toxic, contaminated cough syrups in states like Madhya Pradesh and Rajasthan forced the government to take definitive regulatory action.
2. Rising Substance Misuse: Many popular cough formulations contain active ingredients like codeine or chlorpheniramine, which carry high risks of dependency. The ease of OTC access had fueled widespread addiction and recreational abuse, particularly among youth and vulnerable demographics.

Implementation and Impact on Retailers

With the new rules active, chemists and pharmacies found selling any medicinal syrup without a registered medical practitioner’s prescription will face severe legal penalties, including the potential suspension or cancellation of their retail drug licenses.

While public health activists have strongly lauded the move as a necessary step to protect consumers from toxic contaminants and the dangers of self-medication, some retail pharmacy associations have raised logistical concerns. Industry experts note that the sudden rule change may initially confuse consumers accustomed to buying common cold remedies at their local chemist, putting pressure on primary healthcare facilities for minor ailments.

Nevertheless, the health ministry remains firm: tightening control over liquid medications is non-negotiable to restore global confidence in Indian exports and safeguard citizens at home.